JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on May 23, 2003
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
278/21/19134    most recent
M301580200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balasubramanyam, K.
Right arrow Articles by Kundu, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balasubramanyam, K.
Right arrow Articles by Kundu, T. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print March 6, 2003
J. Biol. Chem, 10.1074/jbc.M301580200
Submitted on February 13, 2003
Revised on March 6, 2003
Accepted on March 6, 2003

Small molecule modulators of histone acetyltransferase p300

Karanam Balasubramanyam, V. Swaminathan, Anupama Ranganathan, and Tapas K. Kundu

Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, Karnataka 560064

Corresponding Author: tapas{at}jncasr.ac.in

Histone acetyltransferases (HATs) are a group of enzymes, which play a significant role in the regulation of gene expression. These enzymes covalently modify the N-terminal lysine residues of histones by the addition of acetyl groups from acetyl-CoA. Dysfunction of these enzymes is often associated with the manifestation of several diseases, predominantly cancer. Here we report that anacardic acid (AA) from Cashew Nut Shell Liquid (CNSL) is a potent inhibitor of p300 and PCAF histone acetyltranferase activities. Though it does not affect DNA transcription, HAT-dependent transcription from a chromatin template was strongly inhibited by AA. Furthermore, we describe the design and synthesis of an amide derivative N- (4-Chloro-3- trifluoromethyl-phenyl)-2-ethoxy-6-pentadecyl-benzamide (CTPB) using anacardic acid as a synthon, which remarkably activates p300 HAT activity but not that of PCAF. Though CTPB does not affect DNA-transcription, it enhances the p300 HAT dependent transcriptional activation from in vitro assembled chromatin template. However, it has no effect on histone deacetylase activity. These compounds would be useful as biological switching molecules for probing into the role of p300 in transcriptional studies and may also be useful as new chemical entities for the development of anticancer drugs.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eukaryot CellHome page
L. Cui, J. Miao, T. Furuya, Q. Fan, X. Li, P. K. Rathod, X.-z. Su, and L. Cui
Histone Acetyltransferase Inhibitor Anacardic Acid Causes Changes in Global Gene Expression during In Vitro Plasmodium falciparum Development
Eukaryot. Cell, July 1, 2008; 7(7): 1200 - 1210.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Sung, M. K. Pandey, K. S. Ahn, T. Yi, M. M. Chaturvedi, M. Liu, and B. B. Aggarwal
Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-{kappa}B-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-{kappa}B{alpha} kinase, leading to potentiation of apoptosis
Blood, May 15, 2008; 111(10): 4880 - 4891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Johnson and R. I. Tapping
Microbial Products Stimulate Human Toll-like Receptor 2 Expression through Histone Modification Surrounding a Proximal NF-{kappa}B-binding Site
J. Biol. Chem., October 26, 2007; 282(43): 31197 - 31205.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
E. D. Eliseeva, V. Valkov, M. Jung, and M. O. Jung
Characterization of novel inhibitors of histone acetyltransferases
Mol. Cancer Ther., September 1, 2007; 6(9): 2391 - 2398.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. T. Smith, M. R. Livingston, A. Mai, P. Filetici, S. F. Queener, and W. J. Sullivan Jr.
Quinoline Derivative MC1626, a Putative GCN5 Histone Acetyltransferase (HAT) Inhibitor, Exhibits HAT-Independent Activity against Toxoplasma gondii
Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1109 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Stimson, M. G. Rowlands, Y. M. Newbatt, N. F. Smith, F. I. Raynaud, P. Rogers, V. Bavetsias, S. Gorsuch, M. Jarman, A. Bannister, et al.
Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity
Mol. Cancer Ther., October 1, 2005; 4(10): 1521 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Grasberger, U. Ringkananont, P. LeFrancois, M. Abramowicz, G. Vassart, and S. Refetoff
Thyroid Transcription Factor 1 Rescues PAX8/p300 Synergism Impaired by a Natural PAX8 Paired Domain Mutation with Dominant Negative Activity
Mol. Endocrinol., July 1, 2005; 19(7): 1779 - 1791.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Huddleson, N. Ahmad, S. Srinivasan, and J. B Lingrel
Induction of KLF2 by Fluid Shear Stress Requires a Novel Promoter Element Activated by a Phosphatidylinositol 3-Kinase-dependent Chromatin-remodeling Pathway
J. Biol. Chem., June 17, 2005; 280(24): 23371 - 23379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Balasubramanyam, R. A. Varier, M. Altaf, V. Swaminathan, N. B. Siddappa, U. Ranga, and T. K. Kundu
Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription
J. Biol. Chem., December 3, 2004; 279(49): 51163 - 51171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Balasubramanyam, M. Altaf, R. A. Varier, V. Swaminathan, A. Ravindran, P. P. Sadhale, and T. K. Kundu
Polyisoprenylated Benzophenone, Garcinol, a Natural Histone Acetyltransferase Inhibitor, Represses Chromatin Transcription and Alters Global Gene Expression
J. Biol. Chem., August 6, 2004; 279(32): 33716 - 33726.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Cheng, N. Yadav, R. W. King, M. S. Swanson, E. J. Weinstein, and M. T. Bedford
Small Molecule Regulators of Protein Arginine Methyltransferases
J. Biol. Chem., June 4, 2004; 279(23): 23892 - 23899.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
X.-J. Yang
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases
Nucleic Acids Res., February 11, 2004; 32(3): 959 - 976.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.